10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001651308-23-000127`
Period End Date	20230630
Filing Date	20230802
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	bgne-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 93 Income Statement 82 Cash Flow Statement 85 Stockholders Equity 36 Comprehensive Income 18

Balance Sheet 93 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.53B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.41B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.87B	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.38B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$196.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$9.69M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.36B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$333.00K	USD	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$105.69M	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.38B	shares	Point-in-time
Short-term investments	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$665.25M	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$299.28M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$173.17M	USD	Point-in-time
Inventories	`InventoryNet`	$282.35M	USD	Point-in-time
Inventories	`InventoryNet`	$321.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$255.05M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$216.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.21B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.40B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.28M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.94M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.51M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$845.95M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$1.03B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$109.96M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$99.42M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$46.90M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$40.62M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$170.41M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$147.55M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.17B	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$1.33B	USD	Point-in-time
Total assets	`Assets`	$5.73B	USD	Point-in-time
Total assets	`Assets`	$6.38B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$294.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$266.98M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$454.95M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$467.35M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$159.03M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$213.86M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$17.07M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$25.19M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$23.51M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$24.04M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$62.52M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$114.33M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$328.97M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	3.05B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$421.05M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.27B	CNY	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.41B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.47B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.50B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$209.15M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$207.43M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.44B	CNY	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$42.03M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$24.28M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$34.52M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$25.82M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$15.65M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$16.00M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$208.78M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$179.62M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$46.09M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$43.12M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$527.41M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$525.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.00B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.93B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,376,251,336 and 1,356,140,180 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$135.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,376,251,336 and 1,356,140,180 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$137.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.54B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.75B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-77.42M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-143.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.81B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.08B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.38B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$6.13B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.77B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.80B	USD	Point-in-time
Total equity	`StockholdersEquity`	$4.16B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.73B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$6.38B	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$341.57M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$595.26M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.04B	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$648.20M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$95.99M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$136.41M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$177.78M	USD	2 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$71.17M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$422.76M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$768.12M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$831.35M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$378.21M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$625.98M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$331.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$723.53M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$395.03M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$375.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$376.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssetsIncludedInOperatingExpenses`	$188.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.73B	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$913.98M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$780.97M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.53B	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-689.97M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-318.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-882.69M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-439.40M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$15.07M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$21.50M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$31.09M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$11.43M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-63.82M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-45.52M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-117.65M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-129.62M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-367.46M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-978.83M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-557.59M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-704.40M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$22.09M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$25.17M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$8.14M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$13.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-729.57M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.00B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-381.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.73M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.28	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.42	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.54	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.75	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.42	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.28	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.75	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.54	USD	2 Qtrs
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.36B	shares	2 Qtrs
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.34B	shares	1 Quarter
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.33B	shares	2 Qtrs
Weighted-average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.36B	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.36B	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	2 Qtrs
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.34B	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.36B	shares	2 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-5.50	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-6.99	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-3.64	USD	1 Quarter
Net loss per American Depositary Share ("ADS") basic (in dollars per share)	`EarningsPerAmericanDepositoryShareBasic`	$-9.75	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-6.99	USD	2 Qtrs
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-5.50	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-3.64	USD	1 Quarter
Net loss per American Depositary Share ("ADS") diluted (in dollars per share)	`EarningsPerAmericanDepositoryShareDiluted`	$-9.75	USD	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.63M	shares	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	104.40M	shares	2 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	102.80M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	104.63M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	104.40M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.63M	shares	2 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	104.63M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	102.80M	shares	1 Quarter

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-729.57M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.00B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-381.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.73M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$42.35M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$32.06M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$146.86M	USD	2 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$178.69M	USD	2 Qtrs
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-2.18M	USD	2 Qtrs
Unrealized losses on equity investments	`IncomeLossFromEquityMethodInvestments`	$-23.53M	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-22.67M	USD	2 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-45.58M	USD	2 Qtrs
Deferred income tax (expense) benefits	`DeferredIncomeTaxesAndTaxCredits`	$-15.00K	USD	2 Qtrs
Deferred income tax (expense) benefits	`DeferredIncomeTaxesAndTaxCredits`	$555.00K	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$767.00K	USD	2 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$6.36M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-307.43M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$131.92M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$31.63M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$53.60M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-32.34M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$30.63M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-30.36M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-32.68M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$21.17M	USD	2 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-8.08M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-72.58M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-76.74M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$88.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.58M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-857.66M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-616.52M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$95.42M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$247.06M	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Purchase of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.58M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.50M	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.05B	USD	2 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$567.50M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$75.00M	USD	2 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	-	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$308.86M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$869.10M	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	-	USD	2 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$15.77M	USD	2 Qtrs
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Repayment of long-term loan	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$67.59M	USD	2 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$161.85M	USD	2 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$115.41M	USD	2 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$66.57M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$18.97M	USD	2 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$35.17M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-28.85M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$146.21M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-71.21M	USD	2 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-50.87M	USD	2 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-453.46M	USD	2 Qtrs
Net decrease in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$152.52M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.88B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.54B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.38B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.88B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.53B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.41B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.87B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$196.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$9.69M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$333.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.28M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.94M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.51M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$32.53M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$24.44M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$10.02M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$12.90M	USD	2 Qtrs
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$58.68M	USD	2 Qtrs
Capital expenditures included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$95.40M	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.38B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$4.38B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$6.13B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$5.77B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$3.80B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquity`	$4.16B	USD	Point-in-time
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.88M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$3.69M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$28.66M	USD	1 Quarter
Exercise of options, ESPP and release of RSUs	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$7.09M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$81.31M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$103.37M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$65.56M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$75.32M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-496.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-84.67M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-66.27M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$18.40M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-99.90M	USD	1 Quarter
Cost from issuance of ordinary shares	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$152.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-729.57M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.00B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-381.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.73M	USD	1 Quarter
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.38B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.36B	shares	Point-in-time
Balance at the end of period	`StockholdersEquity`	$4.38B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$6.13B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$5.77B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$3.80B	USD	Point-in-time
Balance at the end of period	`StockholdersEquity`	$4.16B	USD	Point-in-time

Comprehensive Income 18 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-729.57M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-435.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-348.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.00B	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-381.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.73M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-86.52M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-97.46M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-88.08M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-73.17M	USD	2 Qtrs
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.85M	USD	1 Quarter
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-12.31M	USD	2 Qtrs
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$6.90M	USD	2 Qtrs
Unrealized holding income (loss), net	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.44M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-795.84M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-665.63M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.10B	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-465.81M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.